vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and NorthEast Community Bancorp, Inc. (NECB). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $26.4M, roughly 1.8× NorthEast Community Bancorp, Inc.). NorthEast Community Bancorp, Inc. runs the higher net margin — 40.9% vs -4.8%, a 45.7% gap on every dollar of revenue. On growth, NorthEast Community Bancorp, Inc. posted the faster year-over-year revenue change (3.9% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $50.8M). Over the past eight quarters, NorthEast Community Bancorp, Inc.'s revenue compounded faster (1.8% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
NorthEast Community Bancorp, Inc. (MD) is a U.S.-based bank holding company operating primarily in the Mid-Atlantic region. It provides a comprehensive suite of consumer and commercial banking services, including deposit products, mortgage loans, small business financing, and wealth management solutions to individual and local enterprise clients.
IRWD vs NECB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $26.4M |
| Net Profit | $-2.3M | $10.8M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 59.0% |
| Net Margin | -4.8% | 40.9% |
| Revenue YoY | -47.3% | 3.9% |
| Net Profit YoY | -200.9% | 5.8% |
| EPS (diluted) | $0.01 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $26.4M | ||
| Q3 25 | $122.1M | $27.0M | ||
| Q2 25 | $85.2M | $25.9M | ||
| Q1 25 | $41.1M | $25.5M | ||
| Q4 24 | $90.5M | $25.4M | ||
| Q3 24 | $91.6M | $27.6M | ||
| Q2 24 | $94.4M | $27.0M | ||
| Q1 24 | $74.9M | $25.5M |
| Q4 25 | $-2.3M | $10.8M | ||
| Q3 25 | $40.1M | $11.9M | ||
| Q2 25 | $23.6M | $11.2M | ||
| Q1 25 | $-37.4M | $10.6M | ||
| Q4 24 | $2.3M | $10.2M | ||
| Q3 24 | $3.6M | $12.7M | ||
| Q2 24 | $-860.0K | $12.8M | ||
| Q1 24 | $-4.2M | $11.4M |
| Q4 25 | 14.3% | 59.0% | ||
| Q3 25 | 61.8% | 61.6% | ||
| Q2 25 | 53.2% | 59.5% | ||
| Q1 25 | -70.7% | 57.4% | ||
| Q4 24 | 34.8% | 57.0% | ||
| Q3 24 | 28.0% | 63.6% | ||
| Q2 24 | 26.5% | 65.6% | ||
| Q1 24 | 14.7% | 62.7% |
| Q4 25 | -4.8% | 40.9% | ||
| Q3 25 | 32.8% | 44.0% | ||
| Q2 25 | 27.7% | 43.1% | ||
| Q1 25 | -90.9% | 41.4% | ||
| Q4 24 | 2.5% | 40.1% | ||
| Q3 24 | 4.0% | 45.9% | ||
| Q2 24 | -0.9% | 47.5% | ||
| Q1 24 | -5.6% | 44.5% |
| Q4 25 | $0.01 | $0.78 | ||
| Q3 25 | $0.23 | $0.87 | ||
| Q2 25 | $0.14 | $0.82 | ||
| Q1 25 | $-0.23 | $0.78 | ||
| Q4 24 | $0.03 | $0.74 | ||
| Q3 24 | $0.02 | $0.95 | ||
| Q2 24 | $-0.01 | $0.97 | ||
| Q1 24 | $-0.03 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $81.2M |
| Total DebtLower is stronger | — | $70.0M |
| Stockholders' EquityBook value | $-261.8M | $351.7M |
| Total Assets | $396.9M | $2.1B |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $81.2M | ||
| Q3 25 | $140.4M | $64.3M | ||
| Q2 25 | $92.9M | $59.4M | ||
| Q1 25 | $108.5M | $89.5M | ||
| Q4 24 | $88.6M | $78.3M | ||
| Q3 24 | $88.2M | $97.8M | ||
| Q2 24 | $105.5M | $113.9M | ||
| Q1 24 | $121.5M | $107.4M |
| Q4 25 | — | $70.0M | ||
| Q3 25 | $199.5M | $170.0M | ||
| Q2 25 | $199.3M | $135.0M | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | $7.0M | ||
| Q2 24 | $198.6M | $47.0M | ||
| Q1 24 | $398.3M | $47.0M |
| Q4 25 | $-261.8M | $351.7M | ||
| Q3 25 | $-264.2M | $344.0M | ||
| Q2 25 | $-308.2M | $336.7M | ||
| Q1 25 | $-334.1M | $327.2M | ||
| Q4 24 | $-301.3M | $318.3M | ||
| Q3 24 | $-311.3M | $309.6M | ||
| Q2 24 | $-321.7M | $300.0M | ||
| Q1 24 | $-330.5M | $288.9M |
| Q4 25 | $396.9M | $2.1B | ||
| Q3 25 | $396.1M | $2.1B | ||
| Q2 25 | $342.9M | $2.0B | ||
| Q1 25 | $327.2M | $1.9B | ||
| Q4 24 | $350.9M | $2.0B | ||
| Q3 24 | $389.5M | $2.0B | ||
| Q2 24 | $395.6M | $1.9B | ||
| Q1 24 | $438.8M | $1.9B |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $52.6M |
| Free Cash FlowOCF − Capex | $74.6M | $50.8M |
| FCF MarginFCF / Revenue | 156.3% | 192.3% |
| Capex IntensityCapex / Revenue | 0.0% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 4.86× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $89.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $52.6M | ||
| Q3 25 | $47.6M | $14.1M | ||
| Q2 25 | $-15.1M | $15.6M | ||
| Q1 25 | $20.0M | $10.9M | ||
| Q4 24 | $15.2M | $48.7M | ||
| Q3 24 | $9.9M | $14.4M | ||
| Q2 24 | $33.5M | $11.1M | ||
| Q1 24 | $45.0M | $12.9M |
| Q4 25 | $74.6M | $50.8M | ||
| Q3 25 | $47.6M | $13.6M | ||
| Q2 25 | $-15.1M | $14.9M | ||
| Q1 25 | $19.9M | $10.6M | ||
| Q4 24 | — | $48.2M | ||
| Q3 24 | $9.9M | $14.2M | ||
| Q2 24 | $33.4M | $11.0M | ||
| Q1 24 | $44.9M | $12.8M |
| Q4 25 | 156.3% | 192.3% | ||
| Q3 25 | 39.0% | 50.5% | ||
| Q2 25 | -17.7% | 57.3% | ||
| Q1 25 | 48.4% | 41.4% | ||
| Q4 24 | — | 189.3% | ||
| Q3 24 | 10.8% | 51.5% | ||
| Q2 24 | 35.4% | 40.8% | ||
| Q1 24 | 60.0% | 50.3% |
| Q4 25 | 0.0% | 6.6% | ||
| Q3 25 | 0.0% | 1.6% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.0% | 2.0% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | — | 4.86× | ||
| Q3 25 | 1.19× | 1.18× | ||
| Q2 25 | -0.64× | 1.40× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | 6.74× | 4.77× | ||
| Q3 24 | 2.71× | 1.14× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
